Validation study demonstrates reliability and validity of SARA in ataxia, indicating its utility as a clinical trial endpoint.
The Scale for the Assessment and Rating of Ataxia is a reliable and valid measure of ataxia, making it an appropriate primary outcome measure for clinical trials.
No takes yet. Share an insight, caveat, or question.
Schmitz-Hübsch et al. (2006) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: